Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: Results of an open randomised clinical trial

Gut

Volumn 59, Issue 1, 2010, Pages 98-104

  Angeli, P ^a   Fasolato, S ^a   Mazza, E ^a   Okolicsanyi, L ^b   Maresio, G ^a   Velo, E ^c   Galioto, A ^a   Salinas, F ^d   D'Aquino, M ^d   Sticca, A ^a   Gatta, A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b General Hospital of Treviso   (Italy)

^c Cittadella General Hospital   (Italy)

^d Private Hospital Giovanni XXIII of Monastier   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANRENOATE POTASSIUM; FUROSEMIDE; NITRIC OXIDE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURETIC THERAPY; DRUG DOSE INCREASE; FEMALE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPONATREMIA; INTERMETHOD COMPARISON; KIDNEY BLOOD FLOW; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; UREMIA;

ADULT; AGED; ALDOSTERONE ANTAGONISTS; ASCITES; CANRENOATE POTASSIUM; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 73449129748     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.176495     Document Type: Article

References (21)

1. Arroyo V, Ginés P, Planas R, et al. Management of patients with cirrhosis and ascites. Semin Liv Dis 1986;6:353-69.
2. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003;38:258-66.
3. Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
4. Perez-Ayuso RM, Arroyo V, Planas R, et al. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 1983;84:961-8.
5. Runyon B. Management of adult patients with ascites due to cirrhosis. Hepatology 2004;39:841-56.
6. Santos J, Planas R, Pardo A, et al. Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis; a randomized comparative study of efficacy and safety. J Hepatol 2003;39:187-92.
7. Gatta A, Angeli P, Caregaro L, et al. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991;14:231-6.
8. Bernardi M, Laffi G, Salvagnini M, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver Int 1993;13:156-62.
9. Angeli P, Dalla Pria M, De Bei E, et al. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites. Hepatology 1994;19:72-9.
10. Angeli P, Volpin R, Piovan D, et al. Acute effects of the oral administration of midodrine, an a-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology 1998;28:937-43.
11. Thomsen K, Leyssac PP. Ecute effects of various diuretics on lithium clearance. Renal Physiol 1987;10:65-8.
12. Gentilini P, Casini-Reggi V, Di Fiore G, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999;30:639- 45.
13. Gerbes AL, Bertheau-Reitha U, Falkner C, et al. Advantages of a new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial. J Hepatol 1993;17:353-8.
14. Angeli P, Gatta A. Medical treatment of ascites in cirrhosis. In: Gines P, Arroyo V, Rodes J, Schrier RW, eds. Ascites and renal dysfunction in liver disease. Pathogenesis, diagnosis and treatment. 2nd edn. Malden, MA: Blackwell Publishing, 2005:227-40.
15. Arroyo V, Gines P, Planas R. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large volume paracentesis. Gastroenterol Clin North Am 1992;21:237-56.
16. Arroyo V, Gines A, Salo J. A European survey on the treatment of ascites in cirrhosis. J Hepatol 1994;21:667-72.
17. Lucen MI, Andrade RJ, Tognoni G, et al. Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis. Eur J Clin Pharmacol 2002;58:435-40.
18. Heidelbaugh JJ, SherBondy M. Cirrhosis and chronic liver failure: part II complications and treatment. A Fam Physician 2006;74:767- 76.
19. Sherlock S, Senewiratne B, Scott A, et al. Complications of diuretic therapy in hepatic cirrhosis. Lancet 1996;1:1049-53.
20. Lenaerts A, Codden T, Meunier JC, et al. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system. Hepatology 2006;44:844-9.
21. Fogel MR, Sawhney V, Neal EA, et al. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981;3(Suppl. 1):73-80.